Vicarious Surgical (Vicarious Surgical) Change In Receivables : $0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Vicarious Surgical Change In Receivables?

Vicarious Surgical's change in receivables for the quarter that ended in Dec. 2023 was $0.00 Mil. It means Vicarious Surgical's Accounts Receivable stayed the same from Sep. 2023 to Dec. 2023 .

Vicarious Surgical's change in receivables for the fiscal year that ended in Dec. 2023 was $0.00 Mil. It means Vicarious Surgical's Accounts Receivable stayed the same from Dec. 2022 to Dec. 2023 .

Vicarious Surgical's Accounts Receivable for the quarter that ended in Dec. 2023 was $0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Vicarious Surgical's liquidation value for the three months ended in Dec. 2023 was $76.28 Mil.

Vicarious Surgical Change In Receivables Historical Data

The historical data trend for Vicarious Surgical's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vicarious Surgical Change In Receivables Chart

Vicarious Surgical Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Vicarious Surgical Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Receivables	Get a 7-Day Free Trial									-	-	-	-	-

Vicarious Surgical Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Vicarious Surgical (NYSE:RBOT) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Vicarious Surgical's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0	/	0	*	91
=

2. In Ben Graham's calculation of liquidation value, Vicarious Surgical's accounts receivable are only considered to be worth 75% of book value:

Vicarious Surgical's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	98.177	-	21.895	+	0.75 * 0	+	0.5 * 0
=	76.28

Vicarious Surgical Change In Receivables Related Terms

Thank you for viewing the detailed overview of Vicarious Surgical's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Vicarious Surgical (Vicarious Surgical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vicarious Surgical Inc (NYSE:RBOT) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

78 Fourth Avenue, Waltham, MA, USA, 02451

Website

https://www.vicarioussurgical.com

Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port.

Executives

William John Kelly	officer: CFO and Treasurer	C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
Adam David Sachs	director, 10 percent owner, officer: President and CEO	C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
Sammy Khalifa	director, 10 percent owner, officer: Chief Technology Officer	C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
June Morris	officer: CLO, General Counsel and Sec	C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
John Mazzola	officer: Chief Operating Officer	TRANSMEDICS INC, 200 MINUTEMAN ROAD, ANDOVER MA 01810
Khosla Ventures Opportunity Associates Ii, Llc	10 percent owner	2128 SAND HILL ROAD, MENLO PARK CA 94025
Khosla Ventures V, L.p.	10 percent owner	2128 SAND HILL ROAD, MENLO PARK CA 94025
Khosla Ventures Opportunity Ii, L.p.	10 percent owner	2128 SAND HILL ROAD, MENLO PARK CA 94025
David D Ho	director	UNIT 1008, 10/F, CHAMPION TOWER, 3 GARDEN ROAD, CENTRAL K3 00000
Philip Liang	director	C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
Brendel Victoria Carr	director	C/O VICARIOUS SURGICAL, INC., 78 FOURTH AVENUE, WALTHAM MA 02451
Beverly A Huss	director	C/O ACCURAY INCORPORATED, 1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089
E15 Fund Ii, Lp	other: Sole Shareholder	C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
Shrikant Patnaik	other: Principal	C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
Ric Fulop	director	C/O DESKTOP METAL, INC., 63 THIRD AVENUE, BURLINGTON MA 01803